Trials / Recruiting
RecruitingNCT06537752
A Study to Evaluate Ethanol-induced Symptoms and Safety in Breast Cancer Patients
A Multi-center, Prospective, Observational stuDy to Evaluate EThanOl-induced Symptoms and Safety in Breast Cancer Patients witH Neoadjuvant/Adjuvant Chemotherapy Including Non-ethanol Formulation Docetaxel Before and After Surgery
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 1,052 (estimated)
- Sponsor
- Boryung Pharmaceutical Co., Ltd · Industry
- Sex
- Female
- Age
- 19 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate ethanol-induced symptoms and safety in breast cancer patients with neoadjuvant/adjuvant chemotherapy including Non-ethanol formulation docetaxel before and after surgery
Conditions
Timeline
- Start date
- 2024-07-15
- Primary completion
- 2026-10-01
- Completion
- 2026-10-01
- First posted
- 2024-08-05
- Last updated
- 2025-09-12
Locations
2 sites across 1 country: South Korea
Source: ClinicalTrials.gov record NCT06537752. Inclusion in this directory is not an endorsement.